AlixPartners adds expert to healthcare and life sciences practice

29 November 2019 2 min. read
More news on

Global consultancy AlixPartners has announced that life sciences expert Frank Scholz will joins the firm’s healthcare and life sciences practice. He will be based in Chicago and tasked with helping lead efforts within the pharmaceutical sector.

“We are extremely pleased to welcome Frank to AlixPartners,” Simon Freakley, AlixPartners CEO, said. “Disruption is hitting healthcare and life sciences companies like never before, and Frank’s broad experience and deep knowledge will prove invaluable to clients looking to turn that disruption into advantage.”

Scholz joins AlixPartners from Mallinckrodt Pharmaceuticals, a manufacturer of generic drugs, imaging agents, and specialty pharmaceuticals such as adrenocorticotropic hormone, which is used in medical diagnostic testing to determine adrenocortical insufficiency. There, Scholz served as executive vice president, COO, and digital innovation officer.AlixPartners adds expert to healthcare and life sciences practiceHis other positions at the company included executive vice president of global operations and president of specialty generics, and senior vice president of global operations. Scholz’s duties at Mallinckrodt included overseeing strategic alliances aimed at commercial and R&D, as well as digital innovation, information technology, merger integration, strategic programs, procurement, global quality, and global operations for branded products.

Scholz has nearly two decades of consulting experience, working as a partner at consulting powerhouse McKinsey & Company. He holds a master’s degree in economics from Leibniz University in Hanover, Germany, an MBA from Georgetown University, and a PhD in business management from the University of Bielefeld.

AlixPartners’ healthcare and life sciences practice is headed by managing directors Yogesh Bahl and Eric Hillenbrand. Its recent projects include assisting a medical device company to identify and capture more than $100 million in EBITDA (earnings before interest, taxes, depreciation, and amortization) improvements in an 18-month timeframe. The firm also recently worked with a pharmacy chain to reduce its operating expenses by 14%.

AlixPartners is headquartered in New York, but operates out of offices in more than 20 cities globally. It was founded in 1981 and employs more than 2000 people. It has advised on front-page Chapter 11 reorganizations such as Enron, General Motors, and K-Mart, and works with clients such as corporate boards, law firms, and investment banks.